$19.58
0.673.54%
Pre-Market: 7:35 PM EDT
Comments
Loading...
Rigel Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:RIGL | Benzinga
Rigel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$0.200
Quarterly Revenue Estimate
$44.69M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$179.28M
Analyze the earnings history of Rigel Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RIGL | Rigel Pharmaceuticals | -$0.50 | $0.20 | — | — | $29.53M | $44.69M | — | — | 05/06/2025 | Get Alert |
| RIGL | Rigel Pharmaceuticals | $0.04 | $0.55 | $0.80 | 45.45% | $35.79M | $57.59M | $57.60M | 0.01% | 03/04/2025 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$0.30 | $0.06 | $0.70 | 1066.67% | $28.13M | $41.93M | $55.31M | 31.90% | 11/07/2024 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$0.38 | -$0.29 | -$0.06 | 79.31% | $26.89M | $33.42M | $36.84M | 10.24% | 08/06/2024 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$0.80 | -$0.30 | -$0.50 | -66.67% | $26.07M | $31.28M | $29.53M | -5.58% | 05/07/2024 | Get Alert |
| RIGL | Rigel Pharmaceuticals | $0.10 | -$0.30 | $0.00 | 100.00% | $51.28M | $34.10M | $35.79M | 4.96% | 03/05/2024 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$1.10 | -$0.70 | -$0.30 | 57.14% | $22.41M | $27.20M | $28.13M | 3.43% | 11/07/2023 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$0.80 | -$0.80 | -$0.40 | 50.00% | $29.82M | $26.02M | $26.89M | 3.33% | 08/01/2023 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$1.60 | -$1.00 | -$0.80 | 20.00% | $16.73M | $24.07M | $26.07M | 8.31% | 05/02/2023 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$1.10 | -$1.10 | $0.10 | 109.09% | $20.41M | $27.97M | $51.28M | 83.33% | 03/07/2023 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$1.20 | -$1.30 | -$1.10 | 15.38% | $21.54M | $22.61M | $22.41M | -0.88% | 11/03/2022 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$0.80 | -$1.20 | -$0.80 | 33.33% | $26.27M | $23.65M | $29.82M | 26.08% | 08/02/2022 | Get Alert |
| RIGL | Rigel Pharmaceuticals | $2.20 | -$1.40 | -$1.60 | -14.29% | $81.02M | $17.54M | $16.73M | -4.59% | 05/03/2022 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$1.10 | -$1.30 | -$1.10 | 15.38% | $18.45M | $21.90M | $20.41M | -6.81% | 03/01/2022 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$0.80 | -$1.00 | -$1.20 | -20.00% | $18.39M | $23.56M | $21.54M | -8.56% | 11/02/2021 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$1.00 | -$1.10 | -$0.80 | 27.27% | $16.02M | $20.37M | $26.27M | 28.94% | 08/03/2021 | Get Alert |
| RIGL | Rigel Pharmaceuticals | $1.30 | — | $2.20 | — | $55.76M | $31.05M | $81.02M | 160.93% | 05/05/2021 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$1.00 | -$1.10 | -$1.10 | 0.00% | $15.40M | $18.10M | $18.45M | 1.93% | 03/02/2021 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$0.70 | — | -$0.80 | — | $9.14M | — | $18.39M | — | 11/05/2020 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$1.20 | -$1.30 | -$1.00 | 23.08% | $10.41M | $13.75M | $16.02M | 16.52% | 08/04/2020 | Get Alert |
| RIGL | Rigel Pharmaceuticals | -$1.10 | $1.30 | $1.30 | 0.00% | $12.62M | $56.71M | $55.76M | -1.67% | 05/05/2020 | Get Alert |
Rigel Pharmaceuticals (RIGL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-04 | $0.80 | $0.55 | 45.5 % |
| Q3 | 2024-11-07 | $0.70 | $0.06 | 1066.7 % |
| Q2 | 2024-08-06 | $-0.06 | $-0.29 | 79.3 % |
| Q1 | 2024-05-07 | $-0.50 | $-0.30 | -66.7 % |
Rigel Pharmaceuticals (RIGL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-04 | $57.60M | $57.59M | 0.01 % |
| Q3 | 2024-11-07 | $55.31M | $41.93M | 31.9 % |
| Q2 | 2024-08-06 | $36.84M | $33.42M | 10.2 % |
| Q1 | 2024-05-07 | $29.53M | $31.28M | -5.58 % |
FAQ
When is Rigel Pharmaceuticals (NASDAQ:RIGL) reporting earnings?
Rigel Pharmaceuticals (RIGL) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 4, 2025 for Q4.
What were the latest earnings per share (EPS) for Rigel Pharmaceuticals (NASDAQ:RIGL)?
The Actual EPS was $0.80, which beat the estimate of $0.55.
What were Rigel Pharmaceuticals’s (NASDAQ:RIGL) revenues?
The Actual Revenue was $57.6M, which beat the estimate of $57.6M.
Browse earnings estimates, EPS, and revenue on all stocks.